Newsroom | 19218 results

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Northwell Health’s Center for Gun Violence Prevention has developed a proven approach to firearm injury prevention, and now, with a $650,000, one-year research grant from the Centers for Disease Control and Prevention (CDC), the health system is expanding that work with a focused lens on women’s health. The grant will fund a new study integrating the health system’s universal firearm safety screening and education into routine women’s health care, bringing...

MAPLE GROVE, Minn.--(BUSINESS WIRE)--Urolution Medical, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OpenFlo® Urinary Catheter, marking a major milestone as the company advances toward clinical evaluation and commercialization. Cleared for urinary tract drainage in adult patients for indwell periods of up to 30 days, OpenFlo® incorporates a patented architecture that re-engineers key mechanical features of the conventional Foley cath...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare and Medicaid Services (CMS). Additionally, 42% of Humana Medicare Advantage members are enrolled in 4.5-star plans for 2027.“We’re extremely proud of these Star Ratings. Th...

RICHMOND, Va.--(BUSINESS WIRE)--Genworth Financial, Inc. (NYSE: GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 4, 2026. A conference call will be held on November 5, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results. Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public...

CHICAGO--(BUSINESS WIRE)--SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and data products for health care and not-for-profits, has released the latest benchmarks from its 2026 Health Care Staff Compensation Survey. This survey includes data from nearly 2,600 organizations representing 2.6 million clinical and non-clinical employees – making it one of the industry’s most comprehensive health care...

SAN FRANCISCO--(BUSINESS WIRE)--Abridge today announced an enterprise-wide agreement with University of Texas REAL Health AI to expand access to Abridge’s clinician intelligence platform across the UT System. The agreement provides a systemwide framework through which UT health institutions can access Abridge while preserving local decision-making and supporting responsible implementation of purpose-built AI for healthcare. The combined efforts of UT Health owned and affiliated hospitals and cl...

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines for the treatment of fibrotic diseases with high unmet need, today announced that its Phase 2b WHISTLE-PF trial evaluating taladegib (ENV-101), an investigational Hedgehog signaling pathway inhibitor, met its primary endpoint and multiple key secondary endpoints in patients with idiopathic pulmonary fibrosis (IPF). Current standard-of-care therapies slow the decline of lun...

HOUSTON--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has accepted XCath’s Iris Surgical Robotic System into its Total Product Life Cycle Advisory Program (TAP) Pilot, the company announced today. The system is intended for remote robotic-assisted mechanical thrombectomy in patients with acute ischemic stroke. XCath is a medical device company advancing endovascular surgical robotics, and the FDA’s decision comes after it granted Breakthrough Device Designation to the Iris Syste...

CINCINNATI--(BUSINESS WIRE)--Carefeed, the unified operations platform for senior living and long-term care, today announced that Ellen Kuebrich has joined the company as VP of Growth. Kuebrich will lead sales, marketing, and payments strategy as Carefeed scales its commercial organization across the senior living and long-term care market. Kuebrich brings 20 years of experience in post-acute care to the role. At Providigm, she helped build a 20% share of the national skilled nursing market aro...

NEW YORK--(BUSINESS WIRE)--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations at the 10th Joint ACTRIMS-ECTRIMS Meeting, also referred to as MSToronto2026, being held October 21-23, 2026, in Toronto, Canada. The presentations include a late-breaking oral presentation highlighting initial results from a Phase 1 study evaluating azer-cel in patients with primary progressive multiple sclerosis (PPMS), as well as several presentations highlighting BRIUMVI®...